Difference between revisions of "Template:Next oroboros ecosystem agenda"
| Line 73: | Line 73: | ||
| width="110" align="center" | [[File:MitoPedia.jpg|left|80px|MitoPedia|link=MitoPedia]] | | width="110" align="center" | [[File:MitoPedia.jpg|left|80px|MitoPedia|link=MitoPedia]] | ||
|''' How to interpret cytochrome ''c'' efficiency '''<br> | |''' How to interpret cytochrome ''c'' efficiency '''<br> | ||
Stimulation of OXPHOS or ET capacity upon addition of cytochrome ''c'' provides evidence of cytochrome ''c'' loss, indicating damage of the mitochondrial outer membrane, which could be caused by sample preparation or pathological conditions <br> | Stimulation of OXPHOS or ET capacity upon addition of cytochrome ''c'' provides evidence of cytochrome ''c'' loss, indicating damage of the mitochondrial outer membrane, which could be caused by sample preparation or pathological conditions. <br> | ||
- »'''[https://wiki.oroboros.at/index.php/Cytochrome_c_control_efficiency Cytochrome ''c'' control efficiency]'''« <br> | - »'''[https://wiki.oroboros.at/index.php/Cytochrome_c_control_efficiency Cytochrome ''c'' control efficiency]'''« <br> | ||
- communicated by »[[Schmitt Sabine]]« and »[[Leo Elettra]]« | - communicated by »[[Schmitt Sabine]]« and »[[Leo Elettra]]« | ||
Revision as of 08:06, 9 October 2023
2023 Week 41
- Oct- 09 Mo
- Oct- 10 Tu
What is the best fluorophore and concentration thereof for measuring mt-membrane potential?
It depends on sample characteristics - test the concentration of different fluorophores (safranin, TMRM and rhodamine 123) with your specific model to evaluate for inhibitory or uncoupling effects on respiration.
- »mt-membrane potential measurement«
- communicated by »Grings Mateus« and »Cardoso Luiza«
- Oct- 11 We
- Oct- 12 Th - World Arthritis Day
“Mitochondrial dysfunction did not seem to be a major contributing factor for insulin resistance in RA [rheumatoid arthritis]”
- Moellering DR, Smith-Johnston K, Kelley C, Sammy MJ, Benedict J, Brock G, Johnson J, Baskin KK, Jarjour WN, Belury MA, Reiser PJ, Nagareddy PR, Hanaoka BY (2023) Association between skeletal muscle mitochondrial dysfunction and insulin resistance in patients with rheumatoid arthritis: a case-control study. »Bioblast link«
- from the O2k-Network »US AL Birmingham Moellering_DR«
- Oct- 13 Fr
2023 Week 42
- Oct- 16 Mo
- Oct- 17 Tu
Noticing higher values of J°1 when using the O2k sV-chamber (0.5 mL) compared with the 2mL-chamber?
The instrumental oxygen background is volume-dependent in the closed chamber; therefore, the values of J°1 are about four times higher in the sV chamber.
- »O2k-sV-Module«, »POS calibration-SOP«
- communicated by »Timon-Gomez Alba« and »Leo Elettra«
- Oct- 18 We
- Oct- 19 Th
- Oct- 20 Fr
2023 Week 43
- Oct- 23 Mo
“Thanks for this excellent guidance and support thus far.”
Maarman Gerald J, from the O2k-Network Lab »ZA Cape Town Maarman GJ«
- »O2k-Feedback«
- Oct- 24 Tu
- Oct- 25 We
- Oct- 26 Th
- Oct- 27 Fr
2023 Week 44
- Oct- 30 Mo
- Oct- 31 Tu
How to interpret cytochrome c efficiency
Stimulation of OXPHOS or ET capacity upon addition of cytochrome c provides evidence of cytochrome c loss, indicating damage of the mitochondrial outer membrane, which could be caused by sample preparation or pathological conditions.
- »Cytochrome c control efficiency«
- communicated by »Schmitt Sabine« and »Leo Elettra«
- Nov- 01 We
- Nov- 02 Th
- Nov- 03 Fr
2023 Week 45
- Nov- 06 Mo
- Nov- 07 Tu
- Nov- 08 We
- Nov- 09 Th
- Nov- 10 Fr
2023 Week 46
- Nov- 13 Mo
- Nov- 14 Tu
- Nov- 15 We
- Nov- 16 Th
- Nov- 17 Fr
2023 Week 47
- Nov- 20 Mo
- Nov- 21 Tu
- Nov- 22 We
- Nov- 23 Th
- Nov- 24 Fr
2023 Week 48
- Nov- 27 Mo
- Nov- 28 Tu
- Nov- 29 We
- Nov- 30 Th
- Dec- 01 Fr
2023 Week 49
- Dec- 04 Mo
- Dec- 05 Tu
- Dec- 06 We
- Dec- 07 Th
- Dec- 08 Fr
2023 Week 50
- Dec- 11 Mo
- Dec- 12 Tu
- Dec- 13 We
- Dec- 14 Th
- Dec- 15 Fr
2023 Week 51
- Dec- 18 Mo
- Dec- 19 Tu
- Dec- 20 We
- Dec- 21 Th
- Dec- 22 Fr
2023 Week 52
- Dec- 25 Mo
- Dec- 26 Tu
- Dec- 27 We
- Dec- 28 Th
- Dec- 29 Fr
